Authors: IMONDI AR

Citation: Ar. Imondi, PRECLINICAL MODELS OF CARDIAC PROTECTION AND TESTING FOR EFFECTS OF DEXRAZOXANE ON DOXORUBICIN ANTITUMOR EFFECTS, Seminars in oncology, 25(4), 1998, pp. 22-30

Authors: DESOUZA PL COOPER MR IMONDI AR MYERS CE

Citation: Pl. Desouza et al., 9-AMINOCAMPTOTHECIN - A TOPOISOMERASE-I INHIBITOR WITH PRECLINICAL ACTIVITY IN PROSTATE-CANCER, Clinical cancer research, 3(2), 1997, pp. 287-294

Authors: MAZUE G WILLIAMS GM IATROPOULOS MJ NEWMAN AJ SAMMARTINI U PULCI R CASTELLINO S SCAMPINI G BRUGHERA M IMONDI AR PODESTA A

Citation: G. Mazue et al., ANTHRACYCLINES - REVIEW OF GENOTOXICITY AND CARCINOGENICITY STUDIES, International journal of oncology, 8(3), 1996, pp. 525-536

Authors: IMONDI AR DELLATORRE P MAZUE G SULLIVAN TM ROBBINS TL HAGERMAN LM PODESTA A PINCIROLI G

Citation: Ar. Imondi et al., DOSE-RESPONSE RELATIONSHIP OF DEXRAZOXANE FOR PREVENTION OF DOXORUBICIN-INDUCED CARDIOTOXICITY IN MICE, RATS, AND DOGS, Cancer research, 56(18), 1996, pp. 4200-4204

Authors: HARD GC IATROPOULOS MJ JORDAN K RADI L KALTENBERG OP IMONDI AR WILLIAMS GM

Citation: Gc. Hard et al., MAJOR DIFFERENCE IN THE HEPATOCARCINOGENICITY AND DNA ADDUCT FORMING ABILITY BETWEEN TOREMIFENE AND TAMOXIFEN IN FEMALE CRL-CD(BR) RATS, Cancer research, 53(19), 1993, pp. 4534-4541